­­­­­­­A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS­­­ (2021)

First Author: Reyes L
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16584.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.16584.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research